Simon Sjödin

667 total citations
15 papers, 415 citations indexed

About

Simon Sjödin is a scholar working on Physiology, Neurology and Molecular Biology. According to data from OpenAlex, Simon Sjödin has authored 15 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 7 papers in Neurology and 6 papers in Molecular Biology. Recurrent topics in Simon Sjödin's work include Alzheimer's disease research and treatments (8 papers), Parkinson's Disease Mechanisms and Treatments (6 papers) and Lysosomal Storage Disorders Research (4 papers). Simon Sjödin is often cited by papers focused on Alzheimer's disease research and treatments (8 papers), Parkinson's Disease Mechanisms and Treatments (6 papers) and Lysosomal Storage Disorders Research (4 papers). Simon Sjödin collaborates with scholars based in Sweden, United Kingdom and Denmark. Simon Sjödin's co-authors include Henrik Zetterberg, Kaj Blennow, Ann Brinkmalm, Gunnar Brinkmalm, Annika Öhrfelt, Oskar Hansson, Anja Hviid Simonsen, Steen Gregers Hasselbalch, Erik Portelius and John Hardy and has published in prestigious journals such as PLoS ONE, Movement Disorders and Journal of Neurology.

In The Last Decade

Simon Sjödin

15 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon Sjödin Sweden 10 233 173 144 70 53 15 415
Takayoshi Tokutake Japan 11 272 1.2× 158 0.9× 132 0.9× 71 1.0× 103 1.9× 21 432
Sandra O. Tomé Belgium 12 223 1.0× 189 1.1× 158 1.1× 108 1.5× 67 1.3× 22 464
Lee Marshall United States 10 167 0.7× 330 1.9× 154 1.1× 82 1.2× 71 1.3× 15 580
Valeriya Baru United States 6 185 0.8× 241 1.4× 139 1.0× 120 1.7× 109 2.1× 6 503
Hana Přikrylová Vranová Czechia 11 139 0.6× 106 0.6× 162 1.1× 51 0.7× 43 0.8× 19 336
Sandrine C. Foti United Kingdom 11 156 0.7× 212 1.2× 272 1.9× 157 2.2× 126 2.4× 12 576
Sandra Vilotti Italy 13 101 0.4× 264 1.5× 76 0.5× 103 1.5× 52 1.0× 17 508
Marcella Funicello Italy 8 82 0.4× 133 0.8× 98 0.7× 196 2.8× 26 0.5× 8 434
Martin Broadstock United Kingdom 9 132 0.6× 119 0.7× 94 0.7× 138 2.0× 61 1.2× 16 362
Lenora Higginbotham United States 8 241 1.0× 217 1.3× 42 0.3× 39 0.6× 70 1.3× 14 411

Countries citing papers authored by Simon Sjödin

Since Specialization
Citations

This map shows the geographic impact of Simon Sjödin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Sjödin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Sjödin more than expected).

Fields of papers citing papers by Simon Sjödin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Sjödin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Sjödin. The network helps show where Simon Sjödin may publish in the future.

Co-authorship network of co-authors of Simon Sjödin

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Sjödin. A scholar is included among the top collaborators of Simon Sjödin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Sjödin. Simon Sjödin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Zhang, Hanwen, Daniel Kargilis, Thomas F. Tropea, et al.. (2025). Calcium modulating ligand confers risk for Parkinson's disease and impacts lysosomes. Annals of Clinical and Translational Neurology. 12(5). 925–937. 1 indexed citations
2.
Toft, Anders, Simon Sjödin, Anja Hviid Simonsen, et al.. (2023). Endo‐lysosomal protein concentrations in CSF from patients with frontotemporal dementia caused by CHMP2B mutation. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 15(1). e12402–e12402. 2 indexed citations
3.
Swift, Imogen J., Simon Sjödin, Johan Gobom, et al.. (2023). Differential patterns of lysosomal dysfunction are seen in the clinicopathological forms of primary progressive aphasia. Journal of Neurology. 271(3). 1277–1285. 3 indexed citations
4.
Wasling, Pontus, Lenka Novakova, Simon Sjödin, et al.. (2022). Cerebrospinal fluid amyloid precursor protein as a potential biomarker of fatigue in multiple sclerosis: A pilot study. Multiple Sclerosis and Related Disorders. 63. 103846–103846. 4 indexed citations
5.
Lerche, Stefanie, Simon Sjödin, Ann Brinkmalm, et al.. (2021). CSF Protein Level of Neurotransmitter Secretion, Synaptic Plasticity, and Autophagy in PD and DLB. Movement Disorders. 36(11). 2595–2604. 16 indexed citations
6.
Brockmann, Kathrin, Corinne Quadalti, Stefanie Lerche, et al.. (2021). Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson’s disease and dementia with Lewy bodies. Acta Neuropathologica Communications. 9(1). 175–175. 72 indexed citations
7.
Nilsson, Johanna, Johan Gobom, Simon Sjödin, et al.. (2021). Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 13(1). e12179–e12179. 53 indexed citations
8.
Lowe, Alexander J., Simon Sjödin, Filipe B. Rodrigues, et al.. (2020). Cerebrospinal fluid endo-lysosomal proteins as potential biomarkers for Huntington’s disease. PLoS ONE. 15(8). e0233820–e0233820. 9 indexed citations
9.
Minta, Karolina, Shorena Janelidze, Simon Sjödin, et al.. (2020). Quantification of total apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases. Alzheimer s Research & Therapy. 12(1). 19–19. 30 indexed citations
10.
Sjödin, Simon, Gunnar Brinkmalm, Annika Öhrfelt, et al.. (2019). Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease. Alzheimer s Research & Therapy. 11(1). 82–82. 64 indexed citations
11.
Sjödin, Simon, Oskar Hansson, Annika Öhrfelt, et al.. (2017). Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders. PROTEOMICS - CLINICAL APPLICATIONS. 11(11-12). 25 indexed citations
12.
Brinkmalm, Gunnar, Simon Sjödin, Anja Hviid Simonsen, et al.. (2017). A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's Disease. PROTEOMICS - CLINICAL APPLICATIONS. 12(1). 76 indexed citations
13.
Sjödin, Simon, Annika Öhrfelt, Gunnar Brinkmalm, et al.. (2016). Targeting LAMP2 in human cerebrospinal fluid with a combination of immunopurification and high resolution parallel reaction monitoring mass spectrometry. Clinical Proteomics. 13(1). 4–4. 22 indexed citations
14.
Sjödin, Simon, Marc Mercken, Henrik Zetterberg, et al.. (2015). APLP1 as a cerebrospinal fluid biomarker for γ-secretase modulator treatment. Alzheimer s Research & Therapy. 7(1). 77–77. 8 indexed citations
15.
Sjödin, Simon, et al.. (2013). Global differences in specific histone H3 methylation are associated with overweight and type 2 diabetes. Clinical Epigenetics. 5(1). 15–15. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026